... Journals Publication Model ( https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) Abstract Aims Cardiopulmonary exercise testing (CPET) is often used when athletes present with suspected hypertrophic cardiomyopathy (HCM). While low peak oxygen consumption ( p V ˙ O 2...

... (SVEA) is a marker of foci that may initiate atrial fibrillation (AF) and is associated with worse survival. The types and frequencies of SVEA for predicting postoperative AF (POAF), new-onset AF, and clinical outcomes in obstructive hypertrophic cardiomyopathy (oHCM) remain unknown. Methods...

... This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) Abstract Background Hypertrophic cardiomyopathy (HCM) is a common genetic cardiac disorder and a leading cause...

.... Further research is needed to elucidate the pathogenesis and develop safer and cheaper approaches to diagnose MYH7-induced restrictive cardiomyopathy. MYH7 gene Gene mutation Restrictive cardiomyopathy Hypertrophic cardiomyopathy Case report National Natural Science Foundation of China...

... of SAM, is an uncommon yet critical complication associated with haemodynamic collapse and syncope. This phenomenon warrants heightened attention during PIMSRA for the treatment of HOCM. Hypertrophic cardiomyopathy Percutaneous intramyocardial septal radiofrequency ablation Interventional procedure...

... through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected]. Abstract Background Mitral regurgitation (MR) is a frequent occurrence in hypertrophic cardiomyopathy (HCM), often explained by valvular or sub...

.../licenses/by/4.0/ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background and Aims The feasibility and impact of high intensity exercise programmes in patients with hypertrophic cardiomyopathy (HCM) are unknown...

... and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected]. Abstract Hypertrophic cardiomyopathy (HCM) is a genetic condition primarily...

...-reuse-rights ) Abstract Background and Aims The European Society of Cardiology guidelines recommend a systematic search for diagnostic clues or ‘red flags’ (RFs) in patients with hypertrophic cardiomyopathy (HCM) to better tailor disease management. To date, the prevalence and clinical significance...

... 07 11 2024 27 12 2024 06 02 2025 Conflict of interest: None declared. Corresponding author. Tel: +43 (0)316 385 30173, Email: [email protected] Abstract Background Left ventricular outflow tract obstruction (LVOTO) is common in hypertrophic cardiomyopathy (HCM) but has...

.../ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Aims In light of recent advances in imaging techniques, molecular understanding and therapeutic options in hypertrophic cardiomyopathy (HCM), we performed...

..., distribution, and reproduction in any medium, provided the original work is properly cited. Abstract OBJECTIVES The common surgical treatment in patients with obstructive hypertrophic cardiomyopathy is septal myectomy. This involves resection of a segment of the myocardial septum and can be performed...

... [email protected]. 2024 This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) Abstract Purpose Traditional treatments for obstructive hypertrophic cardiomyopathy...

... explicitly tested for efficacy in patients with HCM, as they were often excluded from study populations, highlighting a significant unmet need in HCM management. ^{2 , 6} Hypertrophic cardiomyopathy (HCM) is the most common inheritable heart disease, caused by pathogenic mutations in sarcomere genes...

... the original work is properly cited. Abstract Background Hypertrophic cardiomyopathy (HCM) is an inherited condition characterized by left ventricular (LV) hypertrophy unexplained by increased afterload, often with concomitant outflow tract obstruction. Verapamil is commonly used to treat symptomatic...

... discussed, as it best mirrors the key concepts of the NYHA classification. ²¹ Abstract Introduction Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiac disease. The impact of HCM on quality of life (QoL) and societal costs remains poorly understood. This prospective...

... adaptation to orthostatic stress in patients with hypertrophic cardiomyopathy with or without syncope and in vasovagal syncope . Am J Cardiol   2002 ; 89 : 1405 – 1410 . 8 Mochizuki   T , Matsuo   Y , Sasaki   M , Morihisa   K , Tabata   S , Fukuda   T , et al...

... according to the following rule: none = 0, trace = 1, trace to mild = 1.5, mild = 2, mild to moderate = 2.5, moderate = 3, moderate to severe = 3.5, and severe = 4. ACE, angiotensin converting enzyme; AF, atrial fibrillation; ARB, angiotensin II receptor blocker; HCM, hypertrophic cardiomyopathy; ICD...

... [email protected]. Abstract Aims Myocardial disarray, an early feature of hypertrophic cardiomyopathy (HCM) and a substrate for ventricular arrhythmia, is poorly characterized in pre-hypertrophic sarcomeric variant carriers (SARC+LVH−). Using diffusion tensor cardiac magnetic resonance (DT-CMR) we...

... indicate the degree of mitral valve competence. As a first-line imaging modality in the management of hypertrophic cardiomyopathy, echocardiography could provide crucial information for surgical decision making. In this article, we focus on elucidating the typical echocardiographic features of systolic...